New medicines from Gilead Sciences Inc., Roche Holding AG, Pharmacyclics Inc. and others are poised to reshape treatment of the most common form of leukemia among adults, potentially eliminating chemotherapy from regimens and extending patients’ lives.
Human immune cells reprogrammed in the laboratory to attack leukemia helped drive out the blood cancer in adults and children with aggressive forms of the disease, according to studies on the new strategy.
Fifty-five, pensionless and assuming he’d have to work until he died, Roger Ulrich had a decision to make. After two decades in the pharmaceutical industry, his position at Merck & Co. had been phased out.
Roche Holding AG’s newly approved medicine Gazyva helped patients with chronic lymphocytic leukemia live almost a year longer without their disease progressing than its top-seller, Rituxan, in a clinical trial.
Cancer patients who took PsiOxus Therapeutics Ltd.’s MT-102 medicine for cachexia tied to the illness gained more weight than those given a placebo in a mid- stage study to be presented next month at a conference in Japan.
Oncologist Bhawna Sirohi hurries to the front of a packed seminar room at Mumbai’s Tata Memorial Hospital on a Thursday afternoon in April. Cramming this meeting into her 12-hour workday, she greets more than three dozen breast cancer patients united by the bright scarves covering their bald heads.
Republican presidential candidates promised to deliver the leadership that Washington needs to overcome congressional gridlock as they pitched their plans for jobs and taxes and called for the removal of Federal Reserve Chairman Ben Bernanke during a debate tonight at Dartmouth College in Hanover, New Hampshire. Participating in the event, sponsored by Bloomberg News and the Washington Post, were former Massachusetts Governor Mitt Romney; Texas Governor Rick Perry; former pizza magnate Herman Cain; Michele Bachmann, a Minnesota congresswoman; Newt Gingrich, the former House Speaker; Ron Paul, a Texas representative; former Pennsylvania Senator Rick Santorum and former Utah Governor Jon Huntsman. Moderators of the debate included PBS talk show host Charlie Rose, Bloomberg reporter
Jackie Fox and Peggy MacDonald share a diagnosis. Both were told by doctors they had a cluster of abnormal cells in one of their breasts that may turn into cancer. Each reacted in vastly different ways to their bad news.